Clinical and Economic Burden of Stroke Among Young, Midlife, and Older Adults in the United States, 2002-2017.

AAPC, average annual percent change HCUP, Healthcare Cost and Utilization Project ICD-9/10-CM, International Classification of Diseases, Ninth/Tenth Revision, Clinical Modification LOS, length of stay NIS, Nationwide Inpatient Sample

Journal

Mayo Clinic proceedings. Innovations, quality & outcomes
ISSN: 2542-4548
Titre abrégé: Mayo Clin Proc Innov Qual Outcomes
Pays: Netherlands
ID NLM: 101728275

Informations de publication

Date de publication:
Apr 2021
Historique:
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 5 2021
Statut: epublish

Résumé

To assess trends of stroke hospitalization rates, inpatient mortality, and health care resource use in young (aged ≤44 years), midlife (aged 45-64 years), and older (aged ≥65 years) adults. We studied the National Inpatient Sample database (January 1, 2002 to December 31, 2017) to analyze stroke-related hospitalizations. We identified data using the Of 11,381,390 strokes, 79% (n=9,009,007) were ischemic and 21% (n=2,372,383) were hemorrhagic. Chronic diseases were more frequent in older adults; smoking, alcoholism, and migraine were more prevalent in midlife adults; and coagulopathy and intravenous drug abuse were more common in young patients with stroke. The hospitalization rates of stroke per 10,000 increased overall (31.6 to 33.3) in young and midlife adults while decreasing in older adults. Although mortality decreased overall and in all age groups, the decline was slower in young and midlife adults than older adults. The mean length of stay significantly decreased in midlife and older adults and increased in young adults. The inflation-adjusted mean cost of stay increased consistently, with an average annual growth rate of 2.44% in young, 1.72% in midlife, and 1.45% in older adults owing to the higher use of health care resources. These trends were consistent in both ischemic and hemorrhagic stroke. Stroke-related hospitalization and health care expenditure are increasing in the United States, particularly among young and midlife adults. A higher cost of stay counterbalances the benefits of reducing stroke and mortality in older patients.

Identifiants

pubmed: 33997639
doi: 10.1016/j.mayocpiqo.2021.01.015
pii: S2542-4548(21)00034-5
pmc: PMC8105541
doi:

Types de publication

Journal Article

Langues

eng

Pagination

431-441

Informations de copyright

© 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.

Références

Stroke. 2006 Oct;37(10):2473-8
pubmed: 16946146
Am J Epidemiol. 2004 Aug 15;160(4):376-83
pubmed: 15286023
JAMA. 2014 Jul 16;312(3):259-68
pubmed: 25027141
Stroke. 2001 Jun;32(6):1360-4
pubmed: 11387499
Stat Med. 2000 Feb 15;19(3):335-51
pubmed: 10649300
Stroke. 2003 Nov;34(11):2693-7
pubmed: 14551402
Clin Geriatr Med. 2009 Nov;25(4):563-77, vii
pubmed: 19944261
Heart Lung Circ. 2014 Jan;23(1):49-55
pubmed: 23791712
Stroke. 2014 Jan;45(1):315-53
pubmed: 24309587
Expert Opin Pharmacother. 2012 Aug;13(12):1751-60
pubmed: 22725675
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Stroke. 2016 Aug;47(8):2090-5
pubmed: 27387990
Am J Public Health. 1988 Jun;78(6):683-5
pubmed: 3369600
Stroke. 2006 May;37(5):1171-8
pubmed: 16556884
J Am Heart Assoc. 2016 May 11;5(5):
pubmed: 27169548
Hum Mol Genet. 1999 Nov;8(12):2325-33
pubmed: 10545614
Rev Esp Cardiol. 2002 Nov;55(11):1124-31
pubmed: 12423568
Stroke. 2001 Aug;32(8):1725-31
pubmed: 11486097
Ann Neurol. 2013 Dec;74(6):778-85
pubmed: 23868398
Circulation. 2020 Mar 3;141(9):e139-e596
pubmed: 31992061
Circulation. 2018 May 8;137(19):e558-e577
pubmed: 29632217
Ann Neurol. 2011 Apr;69(4):619-27
pubmed: 21416498
Cost Eff Resour Alloc. 2003 Dec 19;1(1):8
pubmed: 14687420
Clin Chem. 2009 Sep;55(9):1627-36
pubmed: 19643839
Bull World Health Organ. 2020 May 1;98(5):341-352
pubmed: 32514199
Ann Epidemiol. 2013 Jan;23(1):31-4
pubmed: 23176783
Eur Heart J. 2020 Feb 21;41(8):921-928
pubmed: 31408096
Mayo Clin Proc. 2020 May;95(5):858-866
pubmed: 31902529
JAMA Neurol. 2017 Jun 1;74(6):695-703
pubmed: 28395017

Auteurs

Safi U Khan (SU)

Department of Medicine, West Virginia University, Morgantown, WV.

Muhammad Zia Khan (MZ)

Department of Medicine, West Virginia University, Morgantown, WV.

Muhammad U Khan (MU)

Department of Medicine, West Virginia University, Morgantown, WV.

Muhammad Shahzeb Khan (MS)

Department of Medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL.

Mamas A Mamas (MA)

Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom.
Department of Medicine, Jefferson University, Philadelphia, PA.

Muhammad Rashid (M)

Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom.

Ron Blankstein (R)

Cardiovascular Division, Brigham and Women's Hospital, Boston, MA.

Salim S Virani (SS)

Michael E. DeBakey Veterans Affair Medical Center.
Department of Medicine, Baylor College of Medicine, Houston, TX.

Michelle C Johansen (MC)

Division of Neurology, Johns Hopkins School of Medicine, Baltimore, MD.

Michael D Shapiro (MD)

Section of Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC.

Michael J Blaha (MJ)

Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University, Baltimore, MD.

Miguel Cainzos-Achirica (M)

Division of Cardiovascular Prevention and Wellness, Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center.
Center for Outcomes Research, Houston Methodist, Houston, TX.

Farhaan S Vahidy (FS)

Division of Cardiovascular Prevention and Wellness, Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center.

Khurram Nasir (K)

Division of Cardiovascular Prevention and Wellness, Department of Cardiovascular Medicine, Houston Methodist DeBakey Heart and Vascular Center.
Center for Outcomes Research, Houston Methodist, Houston, TX.

Classifications MeSH